Thymidine kinase deficiency approval brings new hope as drugs doxecitine and doxribtimine receive regulatory clearance,...
The FDA will review tau PET imaging agent MK-6240 on August 13, seeking better Alzheimer...
New data regarding CIDP treatment with efgartigimod PH20 reveals long-term patient outcomes for clinicians based...
High-dose NAC treatment shows promise in reducing brain damage markers in progressive MS patients, according...
New Alzheimer’s blood test shows high reliability matching PET scans, advancing early detection for cognitive...
Discover how minimally invasive spine treatment combines advanced techniques and pain specialists for better outcomes...
Burnout in nurses increases missed care risks, especially in neuro-oncology, with resilience and professional identity...
An experimental Alzheimer's drug shows promising results in a clinical trial by reducing brain damage...
Troubleshoot system block issues causing user access denied errors with expert solutions for seamless login...
Discover latest multiple sclerosis research and clinical trials at the forefront of medical science for...